PRIMUS PHARMACEUTICALS
LIVE

Serial Number

77622816

Owner

PRIMUS PHARMACEUTICALS, INC.

Attorney

Monica L. Dias

First Use Date

Feb 16, 2004

Filing Date

Nov 26, 2008

Add to watchlist:

No watchlists yet
View on USPTO

PRIMUS PHARMACEUTICALS Trademark

Serial Number: 77622816 • Registration: 3704515

PRIMUS PHARMACEUTICALS is a trademark filed by PRIMUS PHARMACEUTICALS, INC. on November 26, 2008. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

PRIMUS PHARMACEUTICALS, INC. (50 trademarks)

WARNER ROBINS, GA 31088

Entity Type: 03

Trademark Details

Filing Date

November 26, 2008

Registration Date

November 3, 2009

First Use Anywhere

February 16, 2004

First Use in Commerce

February 16, 2004

Published for Opposition

August 18, 2009

Goods & Services

Medical foods for use in the dietary management of patients with osteoarthritis; medicated topical prescription preparations having anti-inflammatory properties; [ medicated topical prescription preparations having anti-infective properties; medicated topical prescription preparations having anti-inflammatory and anti-infective properties; medicated topical prescription preparations in the nature of anti-inflammatories and anesthetics for the treatment of dermatosis, hemorrhoids and other skin conditions; ] medical foods for use in the dietary management of patients at risk or with low bone density, osteopenia, osteoporosis; pharmaceutical preparations for the prevention or treatment of low bone density, osteopenia, osteoporosis; [ drug delivery agent consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals; ] medical foods for use in the dietary management of patients with osteoarthritis, rheumatoid arthritis, or other forms of arthritis or inflammatory diseases; pharmaceutical preparations for the treatment of osteoarthritis, rheumatoid arthritis, or other forms of arthritis or inflammatory diseases; [ prescription products, namely, prescription vitamins and prescription drugs for treating osteoarthritis, dermatological, ocular and rheumatological diseases and conditions; ] medical foods for use in the dietary management of patients with osteoarthritis, dermatological, [ ocular ] and rheumatological diseases and conditions

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Dec 14, 2019 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Dec 14, 2019 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Dec 14, 2019 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 14, 2019 APRE
TEAS SECTION 8 & 9 RECEIVED
Nov 1, 2019 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 3, 2018 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 29, 2015 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 29, 2015 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 29, 2015 APRE
TEAS SECTION 8 & 15 RECEIVED
Oct 29, 2015 E815
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 29, 2013 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 29, 2013 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 31, 2011 TCCA
REGISTERED-PRINCIPAL REGISTER
Nov 3, 2009 R.PR
PUBLISHED FOR OPPOSITION
Aug 18, 2009 PUBO
NOTICE OF PUBLICATION
Jul 29, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 15, 2009 PREV
ASSIGNED TO LIE
Jul 15, 2009 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 6, 2009 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 6, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 6, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 6, 2009 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 27, 2009 GNRN
NON-FINAL ACTION E-MAILED
Feb 27, 2009 GNRT
NON-FINAL ACTION WRITTEN
Feb 27, 2009 CNRT
ASSIGNED TO EXAMINER
Feb 25, 2009 DOCK
NEW APPLICATION ENTERED
Dec 1, 2008 NWAP